Enfusion Investor Presentation Deck

Strong profit generation 71.3% 2019 Gross Margin •: enfusion 73.2% 2020 73.6% 1H'2020 73.3% 1H¹2021 Adj. EBITDA¹,2 ($ in millions) $21.1 2019 $25.3 2020 $12.8 1H¹2020 $13.3 1H'2021 Adjusted EBITDA and Adj. EBITDA margin are non-GAAP metrics; definitions can be found on slide 38 and reconciliation to nearest GAAP metric can be found on slide 39 2 Adjusted EBITDA represents earnings before interest, taxes, depreciation and amortization, adjusted to exclude certain items of a non-recurring or unusual nature. 35.8% 2019 Adj. EBITDA Margin¹ PROPRIETARY AND CONFIDENTIAL 31.8% 2020 34.6% 1H'2020 Ⓒ2021 ENFUSION. ALL RIGHTS RESERVED. 26.3% 1H¹2021 34

View entire presentation